Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christer Busch

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Cancer Epidemiology|April 23, 2010
COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67Elin Richardsen, Rebecca Dale Uglehus, Jan Due, et al.
Scandinavian Journal of Urology and Nephrology|November 30, 2006
Prediction of percent Gleason grade 4/5 by multiple core biopsiesAxel Glaessgen, Christer Busch, Mona Norberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causesBirgitta Grundmark, Hans Garmo, Massimo Loda, et al.
Scandinavian Journal of Urology and Nephrology|November 1, 2005
The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancerLars Häggarth, Gert Auer, Christer Busch, et al.
Scandinavian Journal of Urology and Nephrology|November 1, 2005
Prediction of the volume of large prostate cancers by multiple core biopsiesLars Häggarth, Christer Busch, Mona Norberg, et al.
IEEE Transactions on Medical Imaging|January 17, 2013
Blind color decomposition of histological imagesMilan Gavrilovic, Jimmy C Azar, Joakim Lindblad, et al.
European Urology|December 16, 2010
Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al.
Urology|January 10, 2006
Low-grade Ta (noninvasive) urothelial carcinoma of the bladderWillem Oosterlinck, Eduardo Solsona, Hideyuki Akaza, et al.
BJU International|March 9, 2013
Tumour expression of bladder cancer-associated urinary proteinsMårten Lindén, Ulrika Segersten, Marcus Runeson, et al.
The Journal of Pathology|December 25, 2003
A fluid cover medium provides superior morphology and preserves RNA integrity in tissue sections for laser microdissection and pressure catapultingPatrick Micke, Tone Bjørnsen, Stefan Scheidl, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Cancer Epidemiology|April 23, 2010
COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67Elin Richardsen, Rebecca Dale Uglehus, Jan Due, et al.
Scandinavian Journal of Urology and Nephrology|November 30, 2006
Prediction of percent Gleason grade 4/5 by multiple core biopsiesAxel Glaessgen, Christer Busch, Mona Norberg, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causesBirgitta Grundmark, Hans Garmo, Massimo Loda, et al.
Scandinavian Journal of Urology and Nephrology|November 1, 2005
The significance of tumor heterogeneity for prediction of DNA ploidy of prostate cancerLars Häggarth, Gert Auer, Christer Busch, et al.
Scandinavian Journal of Urology and Nephrology|November 1, 2005
Prediction of the volume of large prostate cancers by multiple core biopsiesLars Häggarth, Christer Busch, Mona Norberg, et al.
IEEE Transactions on Medical Imaging|January 17, 2013
Blind color decomposition of histological imagesMilan Gavrilovic, Jimmy C Azar, Joakim Lindblad, et al.
European Urology|December 16, 2010
Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 trial (30993)Willem Oosterlinck, Ziya Kirkali, Richard Sylvester, et al.
Urology|January 10, 2006
Low-grade Ta (noninvasive) urothelial carcinoma of the bladderWillem Oosterlinck, Eduardo Solsona, Hideyuki Akaza, et al.
BJU International|March 9, 2013
Tumour expression of bladder cancer-associated urinary proteinsMårten Lindén, Ulrika Segersten, Marcus Runeson, et al.
The Journal of Pathology|December 25, 2003
A fluid cover medium provides superior morphology and preserves RNA integrity in tissue sections for laser microdissection and pressure catapultingPatrick Micke, Tone Bjørnsen, Stefan Scheidl, et al.
Pageof 4